Abatacept (Orencia): Plattenepithelkarzinome, Hautpapillome, Lymphome und maligne Neoplasmen der Lunge

Last Updated on

20. Oktober 2017 – In Abstimmung mit Swissmedic, dem Schweizerischen Heilmittelinstitut, informiert die Zulassungsinhaberin von Abatacept (Orencia) in der Schweiz, die Bristol-Myers Squibb SA, über Änderungen in der Schweizer Arzneimittelinformation zu Abatacept (Orencia) in der Form einer Direct Healthcare Professional Communication (DHPC).


Gemäss der Mitteilung wurden nach der Markteinführung (Postmarketing) von Abatacept (Orencia) bei Patienten mit rheumatoider Arthritis, die Abatacept (Orencia) (Abatacept) verwendeten, spontane Fälle von Plattenepithelkarzinomen, Hautpapillomen, Lymphomen und malignen Neoplasmen der Lunge beobachtet. Diese gravierenden unerwünschten Ereignisse werden neu in die Abschnitte “Unerwünschte Wirkungen” und “Warnhinweise und Vorsichtsmassnahmen” der Schweizer Arzneimittelinformation zu Abatacept (Orencia) aufgenommen. Nach Einschätzung von Swissmedic und der Zulassungsinhaberin bleibt das sogenannte Nutzen-Risiko-Profil von Abatacept (Orencia) unverändert. Allen Patienten werden jedoch regelmässige Hautuntersuchungen empfohlen, insbesondere wenn weitere Risikofaktoren für Hautkrebs vorliegen sollten.

Seit der ursprünglichen Markteinführung von Abatacept (Orencia) wurden in der Schweizer Arzneimittelinformation von Abatacept (Orencia) Malignitäten unter “Warnhinweise und Vorsichtsmassnahmen” sowie unter “Unerwünschte Wirkungen” schon beschrieben. Dabei wurde darauf hingewiesen, dass Arzneimittel, die wie Abatacept (Orencia) unterdrückend auf das Immunsystem einwirken, die Immunabwehr gegen Malignitäten insgesamt schwächen können.

Seit der Einführung von sogenannten Checkpoint-Inhibitoren wie Pembrolizumab (Keytruda), Ipilimumab (Yervoy), Nivolumab (Opdivo), und anderen in der erfolgreichen Behandlung von gewissen Tumoren durch eine gezielte Stärkung des lokalen Immunsystems, ist es denkbar, dass eine Schwächung des Immunsystems als Auslöser für das Entstehen gewisser Tumore verantwortlich sein kann. Dies ist der wahrscheinliche Mechanismus des mit Abatacept (Orencia) beobachteten Auftretens der hier beschriebenen Malignitäten, obwohl die Zulassungsinhaberin schreibt, dass trotz umfangreicher präklinischer und klinischer Programme, Beobachtungsstudien, permanenter Überprüfung der medizinischen Literatur und kontinuierlicher Überwachung der Postmarketingberichte es immer noch keine ausreichende Evidenz für einen kausalen Zusammenhang zwischen der Anwendung von Abatacept (Orencia) und dem Auftreten von Malignitäten im Allgemeinen oder speziellen Krebsarten gebe.  Der Zusammenhang könnte jedoch sehr wohl kausal sein; immerhin kennt man von einigen immunosupressiven Arzneimitteln das Auftreten von Plattenepithelkarzinoma als schwerwiegende unerwünschte Nebenwirkung schon lange.


Tags: , , , , , ,
About the Author
thassodotcom Professor in Pharmakologie und Toxikologie. Experte in theragenomischer und personalisierter Medizin und individualisierter Arzneimittelsicherheit. Experte in Pharmako- und Toxiko-Genetik. Experte in der klinischen Sicherheit von Arzneimitteln, Chemikalien, Umweltschadstoffen und Nahrungsinhaltsstoffen.

Leave a Reply

Optional: Social Subscribe/Login

Notify of


Here are a few of the web pages we advocate for our visitors.


I have been surfing online more than 2 hours today, yet I never found any interesting article like yours.
It is pretty worth enough for me. In my opinion, if all web owners and bloggers made good content as you did, the net will be a lot more useful than ever before.


Woah! I’m really digging the template/theme of this blog.
It’s simple, yet effective. A lot of times it’s hard to get that “perfect balance” between superb usability
and visual appeal. I must say you’ve done a excellent job with this.
In addition, the blog loads very fast for me on Opera.
Exceptional Blog!


Hi there i am kavin, its my first occasion to commenting anywhere, when i read this piece of writing i thought
i could also create comment due to this sensible paragraph.


Wow, marvelous blog layout! How long have you been blogging for?
you make blogging look easy. The overall look of your web site is great, as
well as the content!


Howdy I am so grateful I found your site, I really found you by error, while I was looking on Aol
for something else, Anyhow I am here now and would just like to say many thanks for a fantastic post and a all round interesting blog (I also love the theme/design), I don’t have time to go through it all at the moment but I
have book-marked it and also included your RSS feeds, so when I have
time I will be back to read a great deal more, Please
do keep up the superb b.


Hello there, You have done an excellent job. I will definitely
digg it and personally recommend to my friends. I am confident they will
be benefited from this site.


I constantly emailed this web site post page to all my friends, for the reason that if like to read it afterward my links will


Very descriptive article, I enjoyed that a lot. Will there be a part 2?


Hurrah! In the end I got a website from where I can truly obtain valuable facts concerning my study and knowledge.


Very shortly this website will be famous amid all blogging people,
due to it’s fastidious articles or reviews


Good way of describing, and fastidious article to
get information on the topic of my presentation subject matter, which i am going to convey in institution of higher education.


Oh my goodness! Incredible article dude! Thank you, However I am encountering problems with your RSS.
I don’t understand why I am unable to subscribe to it. Is there anybody else getting the same RSS issues?
Anyone who knows the solution can you kindly
respond? Thanks!!


I do not know if it’s just me or if perhaps
everybody else encountering issues with your site.
It seems like some of the written text on your content are running off
the screen. Can someone else please provide feedback and let me know if
this is happening to them as well? This may be a
problem with my web browser because I’ve had this happen previously.


Everything composed was actually very reasonable. However,
what about this? suppose you were to write a awesome title?
I ain’t saying your content is not solid.,
but what if you added a post title that makes people desire more?

I mean Abatacept (Orencia): Plattenepithelkarzinome,
Hautpapillome, Lymphome und maligne Neoplasmen der Lunge | thasso is kinda vanilla.

You might glance at Yahoo’s front page and see how they create news titles to grab viewers interested.
You might add a video or a related pic or two to grab people interested about what you’ve got to say.
In my opinion, it might make your posts a little livelier.


I could not refrain from commenting. Exceptionally well written!


I am really thankful to the owner of this website who has shared this enormous post at at this place.


It’s really a great and useful piece of information. I am satisfied
that you shared this helpful information with us. Please stay us informed like this.
Thank you for sharing.


Toll gemachte Website, das Layout gefaellt mir sehr gut!
War sicher ne menge Arbeit.

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • Distinct social profile and high ASD risk, 3q29 deletion survey finds July 19, 2019
    A survey of 93 people with 3q29 deletion syndrome reveals a distinct pattern of social disability and anxiety, even without a diagnosis of autism spectrum disorder. The results were published online in Molecular Autism on July 16.
  • Study sheds light on the darker parts of our genetic heritage July 19, 2019
    More than half of our genome consists of transposons,DNA sequences that are reminiscent of ancient, extinct viruses.Transposons are normally silenced by a process known as DNA methylation, but their activation can lead to serious diseases. Very little is known about transposons but researchers in an international collaboration project have now succeeded for the first time […]
  • Molecular cause for severe multi-organ syndrome July 19, 2019
    Three unrelated families on three continents (from continental Portugal, the United States and Brazil), all with healthy ancestors, had children with a very rare multi-organ condition that causes early-onset retinal degeneration, sensorineural hearing loss, microcephaly, intellectual disability, and skeletal dysplasia with scoliosis and short stature.
  • Researchers determine epigenetic origin of docetaxel-resistant breast cancer July 19, 2019
    Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have published a study in Molecular Cancer Research in which they identify methylation patterns associated with different subtypes of breast cancer, and a subclassification of the group of "triple negatives," a breast cancer type typically associated with poor prognosis. In addition, they identified changes in DNA methylation […]
  • Researchers report the function of reverse-twisting DNA July 19, 2019
    Normally, the two strands of the DNA double helix wind around each other in a right-handed spiral. However, there is another conformation called Z-DNA in which the strands twist to the left. The function of Z-DNA has remained a mystery since its discovery. A newly published paper unambiguously establishes that the Z-conformation is key to […]